Against the backdrop of a prolonged global pandemic, international conflict and a shifting economic climate, the capital markets landscape is ever-changing. Cooley brings you a quarterly webinar series that cuts through the noise and drills down on what you need to know about the current market.
Our inaugural webinar focuses on the current biotech financing environment and deal considerations. Cooley's David Peinsipp and Rich Segal, and Morgan Stanley's Kalli Dircks, managing director of healthcare equity capital markets, provide key insights on financing under current market conditions, including the alternative financing structures companies have been turning to and practical considerations in navigating them.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.